Radical solutions

Nat Biotechnol. 2021 Apr;39(4):391. doi: 10.1038/s41587-021-00908-5.

Abstract

The US RADx program has spawned a phalanx of diagnostic products to market in just 12 months. Its long-term impact on point-of-care, at-home and population testing may be even more profound.

Publication types

  • Editorial

MeSH terms

  • COVID-19 / diagnosis*
  • Direct-To-Consumer Screening and Testing / economics*
  • Drug Development / economics*
  • Early Diagnosis
  • Government Programs / economics
  • Government Programs / organization & administration
  • Humans
  • National Institutes of Health (U.S.)
  • Point-of-Care Systems / economics*
  • United States